PRODUCT LIFE CYCLE TRANSFORMATION: Best Practices for the Digital Era
Sponsored by: Appian
- Digital Transformation
- Product Life Cycle
Date: 9 November
Time: 4PM London/11AM New York
In a recent survey of Global 2000 executives, 87% reported their company had a digital transformation project planned for 2017.
It is clear that digital transformation is a priority.
But what’s also clear is that two-thirds of all digital transformation initiatives end in failure. How can you ensure that your digital transformation program is successful, especially in the highly regulated and ever-changing life sciences and pharmaceutical industry?
Join us for this webinar as we dive into how your organization can achieve digital transformation across the product life cycle. It will feature presentations from Evi Cohen, the VP of Global Pharma & Life Sciences at Appian and Rob Taylor, the Director of Global Regulatory Affairs & Clinical Safety at Merck.
Hear these industry experts explore the current challenges with product development, factors influencing the industry’s path to digital transformation, as well as what is to be expected from pharma going forward. Attendees will learn how to leverage a digital transformation platform to improve and enhance processes while deliver greater efficiency.
Director of Global Regulatory Affairs & Clinical Safety - Merck & Co., Inc.
Rob Taylor is a director with Merck with over 20 years experience leading Global Regulatory Affairs and Clinical Safety teams and programs.
Rob is leading the exploration of innovative, disruptive initiatives to streamline and potentially change the way we use technology to process and manage safety information within Global Clinical Safety and Pharmacovigilance.
Vice President, Global Pharma & Life Sciences at Appian
Evjatar (Evi) Cohen has over 19 years of pharmaceutical industry experience in Legal Affairs, Research & Development, Quality Assurance, Regulatory Affairs and Project Management. He joined Appian as the Global Pharma & Life Sciences Lead, responsible for ensuring client success and continued steady growth in license revenues across all pharmaceutical clients. His previous positions include Vice President of Global Innovation & Portfolio Management at Catalent Pharma Solutions and Director of Legal Affairs at Teva Pharmaceuticals.
Evi holds an MBA in Pharmaceutical Management, and an MS in Biotechnology, Biochemistry and Food Science from Drexel University in Philadelphia, and a BS in Chemistry from The Hebrew University of Jerusalem.
Key Learning Objectives
- Leverage a digital transformation platform and best practices to improve probability of success
- Enable mobility, low-code development, and rapid deployment with information technology
- Use innovation to leverage proven technology while enhancing processes and delivering greater efficiency
- Chief Supply Chain Officer
- Chief Compliance Officer
- Dir/VP of Clinical Operations
- Regulatory Affairs
- Chief Digital/Innovation Officer
- IT Executive
- Safety Tracking
- Safety Surveillance